retatrutide obesity trial results Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating and its complications: #type2diabetes #cardiovascular disease Retatrutide, a TRIPLE agonist (GLP1,
Description
doi:10.3389/fendo.2021.738848 81
94 , 95 The FDA authorized tofogliflozin for diabetic therapy in 2014
Standardized data extraction and management A pre-piloted, standardized computerized data extraction form was created in Microsoft Excel, and data from the included studies was manually entered into it by two reviewers (KK and KP)
Many also noted better eating habits (65%) and improved mental health (60%), reinforcing the idea that GLP-1s may offer more than just weight loss
Always check your benefits during the open enrollment period
